| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/2008 | WO2008116135A3 Topical formulations having enhanced bioavailability |
| 12/24/2008 | WO2008114800A3 Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| 12/24/2008 | WO2008109832A3 Viable near-infrared fluorochrome labeled cells and methods of making and using same |
| 12/24/2008 | WO2008109462A3 Sustained release pellets comprising wax-like material |
| 12/24/2008 | WO2008101179A3 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/24/2008 | WO2008100807A3 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/24/2008 | WO2008100240A3 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
| 12/24/2008 | WO2008098180A3 Complementary personal lubrificant compositions and delivery system |
| 12/24/2008 | WO2008078341A3 Stable pharmaceutical formulations of atorvastatin magnesium salt |
| 12/24/2008 | WO2008063465A3 Encapsulated pancreatic islet cell products and methods of use thereof |
| 12/24/2008 | WO2008054823A3 Bolus materials for radiation therapy and methods of making and using the same |
| 12/24/2008 | WO2008051818A3 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 12/24/2008 | WO2008051291A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 12/24/2008 | WO2008048272A3 Method of drug delivery by carbon nanotube-chitosan nanocomplexes |
| 12/24/2008 | WO2008023064A3 Use of a composition for skin treatment during x-ray irradiation |
| 12/24/2008 | WO2008017472A3 Method for the production of a porous, ceramic surface layer |
| 12/24/2008 | WO2008011556A3 Film-delivering rinse |
| 12/24/2008 | WO2007095175A3 Thermo-responsive materials |
| 12/24/2008 | WO2007089926A3 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 12/24/2008 | WO2007070694A3 Spray-on formulations and methods for dermal delivery of drugs |
| 12/24/2008 | WO2006002769A3 Hollow fibre and the use thereof |
| 12/24/2008 | EP2005990A2 Microneedle device and transdermal administration device provided with microneedles |
| 12/24/2008 | EP2005968A2 Nanocomposite particle |
| 12/24/2008 | EP2005959A1 External pharmaceutical composition |
| 12/24/2008 | EP2005958A1 External pharmaceutical composition |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2005948A2 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 12/24/2008 | EP2005946A1 Method for producing extended release tablet |
| 12/24/2008 | EP2005945A2 Oseltamivir phosphate granule and preparation mehtod thereof |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2005845A1 Disperse base material |
| 12/24/2008 | EP2004252A2 Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof |
| 12/24/2008 | EP2004235A2 Composition for cosmetic or pharmaceutical-dermatological use |
| 12/24/2008 | EP2004199A1 Treatment of menopause-associated symptoms |
| 12/24/2008 | EP2004190A1 Non-codeine opioid analgesic process and formulations |
| 12/24/2008 | EP2004168A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists |
| 12/24/2008 | EP2004154A2 Therapeutic belt |
| 12/24/2008 | EP2004152A2 Multi-membrane immunoisolation system for cellular transplant |
| 12/24/2008 | EP2004151A1 Oral pharmaceutical coated composition for pulsatile release |
| 12/24/2008 | EP2004150A1 Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer. |
| 12/24/2008 | EP2004149A1 Pharmaceutical compositions containing leflunomid |
| 12/24/2008 | EP2004148A2 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 12/24/2008 | EP2004147A2 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 12/24/2008 | EP2004146A1 A tablet of paracetamol containing an encapsulated flavorant |
| 12/24/2008 | EP2004145A2 Alkylene-dicarboxylate-containing biodegradable poly(ester amides) and methods of use |
| 12/24/2008 | EP2004144A1 Method for obtaining hollow particles |
| 12/24/2008 | EP2004143A2 Compositions including relatively water insoluble/unwettable drugs and methods for using same |
| 12/24/2008 | EP2004142A2 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 12/24/2008 | EP2004141A2 An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| 12/24/2008 | EP2004140A1 Delivery means |
| 12/24/2008 | EP2004139A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment |
| 12/24/2008 | EP2004138A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 12/24/2008 | EP2003990A2 Association of oleaginous substance with a mixture of at least two cyclodextrins |
| 12/24/2008 | EP2003970A2 Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin |
| 12/24/2008 | EP1973601A4 Iontophoretic transdermal delivery of nicotine salts |
| 12/24/2008 | EP1898876B1 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical presentations |
| 12/24/2008 | EP1765304B1 Compressed chewing gum tablet |
| 12/24/2008 | EP1706095B1 Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 12/24/2008 | EP1651200B1 Galloylpeptides |
| 12/24/2008 | EP1631373B1 Micropellets, method for the production thereof, and use thereof |
| 12/24/2008 | EP1603550B1 Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid |
| 12/24/2008 | EP1581181B1 Controlled release depot formulations |
| 12/24/2008 | EP1562568B1 Treatment of heaves |
| 12/24/2008 | EP1534508B1 Embossable and writable multilaminate backing construction |
| 12/24/2008 | EP1480622B1 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 12/24/2008 | EP1401418B1 Topical treatments using alkanolamines |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1379219B1 Large, porous particles produced by controlling humidity during a spray draying process |
| 12/24/2008 | EP0850047B1 Therapeutic lipidic vesicles: methods of use and compositions |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | DE202007018534U1 Vorrichtung zum Trocknen von Granulaten oder Pellets Device for drying granules or pellets |
| 12/24/2008 | DE102007029471A1 Neue fakultativ kationische Sterole New optional cationic sterols |
| 12/24/2008 | DE102007028912A1 Procedure for drying of granulates or pellets e.g.tablets, pills and capsules in a container with circular cross-section and tappet arranged in the container, comprises rotatably driving the container around its longitudinal axis |
| 12/24/2008 | DE102007028777A1 Transportvorrichtung Transport device |
| 12/24/2008 | CN101331229A Immunostimulatory oligoribonucleotides |
| 12/24/2008 | CN101331173A Biocompatible block copolymer, use thereof, and production method thereof |
| 12/24/2008 | CN101330935A Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 12/24/2008 | CN101330920A Liquid medicine for internal use |
| 12/24/2008 | CN101330913A Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 12/24/2008 | CN101330912A Pharmaceutical composition of docetaxel, preparation method and purpose |
| 12/24/2008 | CN101330910A Bisoprolol-containing adhesive patch |
| 12/24/2008 | CN101330908A Adhesive preparation |
| 12/24/2008 | CN101330907A Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 12/24/2008 | CN101330906A HCV prodrug formulation |
| 12/24/2008 | CN101330905A Lyophilization process and products obtained thereby |
| 12/24/2008 | CN101330904A Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same |
| 12/24/2008 | CN101330903A Abuse resistant transmucosal drug delivery device |
| 12/24/2008 | CN101328487A Preparation of fermentation liquor of Coprinus comatus liquid conversion mulberry leaf and use thereof |
| 12/24/2008 | CN101328476A Nucleic acid molecule NRN1SR32 and use thereof in anti-cancer medicine preparation |
| 12/24/2008 | CN101328475A Nucleic acid molecule NRN1SR11 and use thereof in anti-cancer medicine preparation |
| 12/24/2008 | CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug |
| 12/24/2008 | CN101328219A Nano liposome anti-HPV, gynecological inflammation pathogen specific compound IgY and combined preparation thereof |
| 12/24/2008 | CN101327357A Dacryon plug for conveying promoting agent |
| 12/24/2008 | CN101327356A Dacryon plug for conveying promoting agent |
| 12/24/2008 | CN101327326A Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility |
| 12/24/2008 | CN101327325A Ophthalmologic irrigation solutions and method |
| 12/24/2008 | CN101327323A Lyophilization technique for preparing lyophilized hepatitis A attenuated live vaccine |
| 12/24/2008 | CN101327321A Soft capsules containing lactase |
| 12/24/2008 | CN101327320A Enzyme treatment for infection |